Insider Shareholders with Direct Ownership of Onconova Therapeutics, Inc. (ONTX)
This section provides a comprehensive overview of the insiders with direct ownership of Onconova Therapeutics, Inc. (ONTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Onconova Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Armistice Capital, Llc
> 10% Shareholder |
0 | 10,249 | 816,702 $481,854 | 1 |
Sep 23, 2019
Reduced 1.24%
|
|
Iain D. Dukes
Chief Executive Officer |
171,180 | 0 | 171,130 $100,966 | 2 |
Dec 12, 2025
Added 17.75%
|
|
Nikolay Savchuk
Chief Operating Officer |
150,656 | 0 | 150,606 $88,857 | 2 |
Dec 12, 2025
Added 9.83%
|
|
Charles David Pauza
Chief Science Officer Virology |
115,971 | 0 | 115,971 $68,422 | 2 |
Dec 12, 2025
Added 13.74%
|
|
Robert Redfield
Chief Medical Officer |
113,919 | 0 | 113,919 $67,212 | 2 |
Dec 12, 2025
Added 12.6%
|
| 301,222 | 0 | 109,222 $64,440 | 3 |
Dec 12, 2025
Added 4.27%
|
|
|
Steven M Fruchtman
PRESIDENT, CHIEF EXECUTIVE OFF |
153,265 | 34,222 | 74,792 $44,127 | 13 |
Mar 14, 2024
Reduced 10.45%
|
|
Mark Patrick Guerin
Chief Financial Officer |
79,335 | 13,392 | 39,255 $23,160 | 17 |
Jun 18, 2024
Reduced 5.35%
|
|
Abraham N. Oler
SVP Corp Dev & Gen Counsel |
76,381 | 0 | 24,514 $14,463 | 10 |
Jan 28, 2022
Added 5.77%
|
| 69,726 | 0 | 21,334 $12,587 | 3 |
Sep 28, 2021
Added 21.81%
|
|
|
Mark S. Md Gelder
CHIEF MEDICAL OFFICER |
12,864 | 2,377 | 10,487 $6,187 | 5 |
Feb 07, 2023
Reduced 10.59%
|
| 56,892 | 0 | 6,292 $3,712 | 3 |
Dec 12, 2025
Added 49.46%
|
|
| 6,157 | 0 | 6,165 $3,637 | 1 |
Dec 12, 2025
Added 49.97%
|
|
| 6,157 | 0 | 6,157 $3,632 | 1 |
Dec 12, 2025
Added 50.0%
|
|
| 4,058 | 0 | 4,058 $2,394 | 1 |
Dec 12, 2025
Added 50.0%
|
|
|
Tpav, Llc
> 10% Shareholder |
0 | 605,531 | 0 $0 | 1 |
Apr 02, 2025
Reduced 100.0%
|